Profile: Halozyme Therapeutics is a biopharmaceutical company developing products that target the extracellular matrix for the endocrinology, oncology, dermatology and drug delivery markets. We offer a family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. Our Enhanze™ technology is a drug delivery platform designed to increase the absorption and dispersion of biologics. Our PEGPH20 program utilizes pegylated hyaluronidase that allows for intravenous administration to degrade the hyaluronan that surrounds tumor cells.